RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR

Clinical trial NCT06571825 · RECRUITING

Trial details

NCT number: NCT06571825
Sponsor: He Huang
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2024-07-17
Primary completion: 2027-12-30
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.